Abstract: UNLABELLED: PAIN OUT is a European Commission-funded project aiming at improving postoperative pain management. It combines a registry that can be useful for quality improvement and research using treatment and patient-reported outcome measures. The core of the project is a patient questionnaire-the International Pain Outcomes questionnaire-that comprises key patient-level outcomes of postoperative pain management, including pain intensity, physical and emotional functional interference, side effects, and perceptions of care. Its psychometric quality after translation and adaptation to European patients is the subject of this validation study. The questionnaire was administered to 9,727 patients in 10 languages in 8 European countries and Israel. Construct validity was assessed using factor analysis. Discriminant validity assessment used Mann-Whitney U tests to detect mean group differences between 2 surgical disciplines. Internal consistency reliability was calculated as Cronbach's alpha. Factor analysis resulted in a 3-factor structure explaining 53.6% of variance. Cronbach's alpha at overall scale level was high (.86), and for the 3 subscales was low, moderate, or high (range, .53-.89). Significant mean group differences between general and orthopedic surgery patients confirmed discriminant validity. The psychometric quality of the International Pain Outcomes questionnaire can be regarded as satisfactory. PERSPECTIVE: The International Pain Outcomes questionnaire provides an instrument for postoperative pain assessment and improvement of quality of care, which demonstrated good psychometric quality when translated into a variety of languages in a large European and Israeli patient population. This measure provides the basis for the first comprehensive postoperative pain registry in Europe and other countries. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 3 Abstract PAIN OUT is a European Commission-funded project aiming at improving postoperative pain (POP) management. It combines a registry that can be useful for quality improvement (QI) and research using treatment and patient-reported outcome measures. Core of the project is a patient questionnaire -the International Pain Outcomes questionnaire (IPO) that comprises key patient level outcomes of POP management including pain intensity, physical and emotional functional interference, side effects, and perceptions of care. Its psychometric quality after translation and adaptation to European patients is the subject of this validation study. The questionnaire was administered to 9,727 patients in 10 languages in eight European countries and Israel. Construct validity was assessed using factor analysis (FA).
. According to Glicklich & Dryer, "a patient registry is an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure and that serves a predetermined scientific, clinical, or policy purpose(s)" 14 .Registries are able to provide a picture of medical treatment strategies applied and related patient outcomes closer to clinical routine than randomized controlled trials (RCTs) do, since they include heterogeneous patients, often elderly and those burdened with co-morbidities. Registries offer the possibility for continuous benchmarking of treatment outcomes, evaluation of interventions, and can facilitate best practice 25 . Although several registry initiatives in the field of pain exist on national level 25, 27 , so far, there is no comprehensive, multi-national registry in pain medicine.
The European Commission funded PAIN OUT project combines a quality improvement (QI) approach with a registry and development of a clinical decision support system to advance the quality of acute postoperative pain management and research in this field in Europe 37 . Feasibility of this approach has been pilot tested and is reported elsewhere 41 . Based on the registry data, two tools are provided to clinicians to facilitate pain management in participating hospitals: a patient outcomes survey benchmark module providing online feedback for internal and external benchmarking; and a clinical decision support system based on case based reasoning. A third tool is an electronic knowledge library, providing easy access to existing guidelines in acute pain. PAIN OUT is being developed and tested by a total of 17 research and clinical partners receiving EU funding, out of which 11 clinical sites in 9 countries (France; Germany; Italy; Israel; Romania; Spain; Sweden; Switzerland; United Kingdom) carry out data collection.
International recognition in an early stage of the project led to an expansion of PAIN OUT to 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Outcomes questionnaire (APS-POQ-R) 17 . Consequently, the group decided to use the APS-POQ-R that has established preliminary psychometrics as a starting point for the project"s patient outcomes questionnaire. Several additional questions were added, as a basis for further testing of categorical scaling and adaptation of patient reported outcomes to the postoperative setting in a European population. The APS-POQ has an almost 20-year history of iterative improvement and can be regarded as an instrument with satisfactory psychometric properties 33, 15, 16, 10 . The latest version of the APS questionnaire (the APS-POQ-R) was revised and validated in 2010 17 and covers five aspects of outcome measurement in acute pain: pain severity, interference with function, affective experience, side effects, and perceptions of care. It was adapted to the postoperative setting and translated into all languages required by the PAIN OUT project following a strict forward and backward
procedure. An interdisciplinary group of experts (nurses, physicians, a psychologist, a statistician, and a computer scientist) carried out the present validation study. Therefore the purpose of this paper is to report on the psychometric quality of the questionnaire after its translation and adaptation to the requirements of the postoperative setting.
Material and Methods

Overview
6
In summary, the validation procedure was carried out in two phases (see figure 1) . In phase one, the 23 question APS-POQ-R was supplemented with five additional items proposed by experts in the PAIN OUT group as possible alternative wording and categorical scaling (see below for details). A total of 5,134 patients from 1 to 3 sites in each of the 9 countries completed the resulting first version of the instrument between February and December 2010
that from now on is termed the International Pain Outcomes questionnaire (IPO). Results from this first phase of data collection are presented in Supplemental Information 2.
Preliminary psychometric analysis and feedback received from patients and research assistants, resulted in further adaptation of the questionnaire. In phase two, from February until October 2011, the modified questionnaire was administered to a new group of 4,590 patients, and its psychometric properties were again assessed. Presentation of results focuses on this second assessment. Details of the two phases are described below.
(Insert figure 1 here)
Material
Patient selection & eligibility:
The study protocol was reviewed by the Institutional Review Board or Ethics Committee at all sites. All study procedures were in accordance and compliance with the regulations and the institutions" policies and guidelines for protection of human subjects. Eligible patients were identified from inpatient orthopedic and general surgery census lists. Where research assistants did not have sufficient capacity to approach all eligible patients, PAIN OUT Standard Operating Procedures provided clear guidance on how to achieve a random selection. Surgical patients were approached in their hospital room on postoperative day number one, and invited to participate by a Research Assistant (RA) using a consent form as determined by local Institutional Review Boards. Patients had to be of consenting age (varying in the European countries from 16-18 years) or over; able to communicate; and not cognitively impaired. All patient outcome data were collected on postoperative day 1, when patients were back on the ward for at least 6 hours. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 7 patient too weak to fill it in independently) were interviews by the RAs allowed. The RAs also filled in a supplemental assessment form for the first 300 patients at their site, pointing out any difficulties and ambiguities with items that were encountered. After the end of phase 1, a feedback meeting with RAs was held to evaluate experiences with the IPO.
Questionnaire:
The APS-POQ-R covers the following areas: pain severity (4 items), pain interference with physical function (4 items) and affect (4 items), adverse effects (4 items), and perceptions of care (6 items) plus an item on use of non-pharmacological treatments deemed unreliable if obtained from medical records. The five supplemental items introduced by the PAIN OUT expert group in phase 1 of the data collection addressed categories of time spent in severe pain; patient"s wish for more pain treatment than received; patient"s wish for less pain treatment than received; sleep quality; and pre-operative chronic pain conditions. Taking into account the results of psychometric analysis of phase 1 data and feedback from patients and RAs, the expert group decided on a final set of items for phase 2, as presented in Supplemental Information 3. This final version of the IPO was re-administered and reassessed in a new prospective population of patients from the same clinical sites as in phase 1.
Methods
Translation procedure: The translation of the questionnaire from English was carried out according to international scientific standards 40, 3 . A translation agency working with native speakers for each language conducted the work. . Given skewed distributions, the appropriateness of this approach was confirmed using the Kaiser-MeyerOlkin-(KMO) and Bartlett tests. Reliability testing used Cronbach"s alpha for internal consistency of the overall questionnaire and of the subscales identified in factor analysis 6, 26 .
In addition, discriminant validity was assessed using the contrasting groups approach.
Specifically, we used Mann-Whitney U tests and Chi-squared tests to assess whether the questionnaire items would distinguish between general surgery and orthopaedic surgery patient-outcomes. T-tests were run in parallel for comparison purposes. All analyses were carried out using STATA/MP 10.1 and 11.0 (StataCorp, College Station, Texas, USA) and SPSS 18.0 (SPSS Inc., Chicago, Illinois, USA).
Results
Patient accountability and characteristics
In phases 1 and 2, the patient outcome questionnaire was completed by 5,134 and 4,590 patients, respectively. Regarding preoperative chronic pain, 49.3% of patients suffered from persistent pain before surgery, its intensity being 6.4 NRS points. In 59.9% of cases the persistent pain was at the site of surgery, in 10.8% was elsewhere, and in 29.3% was present both at the site of surgery and in other body areas. A total of 16.9% of patients would have wished more pain treatment than they received.
Adaptation of questionnaire
The phase 1 questionnaire showed favorable psychometric properties overall (see Supplemental Information 2), which supports previous work by the APS 17 . Further adaptation leading to phase 2 aimed both at shortening the instrument without loss of 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 substantial information and at adapting it to the needs of the European patient population.
The following changes were made:
1. The two pain interference items on "falling asleep" and "staying asleep" were combined into a single new item asking whether "pain interfered with or prevented you from sleeping", since the two original items had a high inter-item-correlation of r=.84, the highest of the whole correlation matrix.
2. A new item asking whether "pain interfered with or prevented you from breathing deeply or coughing" was introduced, as this was regarded by the expert group as being of high clinical importance, especially for patients undergoing general surgery. 4. Two of the four emotional impairment items ("frightened" and "depressed") were removed. Both had a high inter-item correlation (r=.67 and r.=65, respectively) with the "anxious" item. Apart from high inter-item correlations there were lingual and cultural reasons for taking out the two items "depressed" and "frightened". In many languages both translators and patients had difficulties in telling the difference between "frightened" and "anxious". Since "anxious" was clearer to most patients we decided to keep "anxious". Another reason was that many patients in various countries reacted irritated on the item "depressed".
5. The item "How often did a nurse or doctor encourage you to use non-medicine methods?" was removed, since in 76.5% of cases the answer was "never". In addition, in some countries this item was regarded as difficult to understand. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11 medical record-based information on the presence of chronic pain (as collected on the phase 1 process questionnaire) proved to not be sufficiently reliable. Of the items not included in the phase 2 questionnaire, "would you have liked less pain treatment than you received?" (yes/no) was only answered 'yes' by 3.8 % of patients. "Did you wake up due to pain?" slightly decreased Cronbach"s alpha for the "pain intensity and interference" sub-scale when replacing "interference with staying asleep". Finally, the original APS-POQ-R item "percentage of time spent in severe pain" was not replaced by the alternative using a categorical answer format due to marginal impact on internal consistency results.
Results after adaptation of questionnaire
Exploratory factor analysis
The appropriateness of using exploratory factor analysis on the phase 2 set of 16 NRS items to assess construct validity was confirmed by the results of the KMO test (0.901) and the Bartlett test (p < 0.001). Principal component analysis with promax rotation was used.
Pairwise exclusion of missing values resulted in case numbers ranging from 3,186 to 4,585.
The factor analysis generated a three factor solution (Eigen value >1), explaining a total variance of 53.8 %. The factor loadings per item are displayed in table 4. The group of pain intensity and interference items forms one factor together with the two remaining "affective impairment" items, explaining 36.0 % of variance. The factors "adverse effects" and "perceptions of care", explaining 10.3% and 7.5% of variance, remained unchanged.
Internal consistency reliability
Cronbach"s alpha and related statistics is displayed in table 5. Overall Cronbach"s alpha was 0.86. As in phase 1, the subscale "pain intensity and interference (physical and emotional)" achieved the best Cronbach"s alpha (r=.89), followed by "adverse effects" (r=.67) and "perceptions of care" (r=.55). 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 12 For all NRS items but one, a significant difference between the general surgery and orthopedic patient groups was observed (see table 6 ). Exception was "nausea" with an almost equal mean in orthopedic and general surgery patients (1.67 and 1.75 respectively).
Discriminant validity
All pain intensity items, both items on affective impairment and three interference items were significantly increased in orthopedic patients. The new item on "pain interference with breathing/coughing" had an increased mean value in general surgery patients. Both adverse effects "dizziness" and "drowsiness" were also increased in general surgery patients, "itching" was slightly increased in orthopedic patients. As in phase 1, "percentage of pain relief" and "satisfaction with pain treatment" showed significantly higher scores in the patients treated in general surgery, while the item "participation in decision making" was again increased in orthopedic patients.
Discussion
The PAIN OUT project establishes a registry that can be used for local QI benchmarking or larger scale research studies using patient-reported outcome data, demographics, with realworld perioperative treatment details 41 . Unlike most registries that contain only medical record audit data, PAIN OUT incorporates a self-reported patient questionnaire (IPO), comprising key outcome of postoperative pain management including pain intensity, physical and emotional functional interference, side effects, and perceptions of care. The psychometric quality of the IPO after translation and adaptation to European patients is the focus of this validation study. The aim followed in this paper was not to examine differences between different language versions, but to test how the IPO performs overall in this European population. Reports on the psychometric quality of the instrument for each language separately will be published elsewhere as will focused analysis of perioperative treatment data obtained from the medical record reviews. To our knowledge this is the first study validating a multi-dimensional outcomes questionnaire in a comprehensive, two-step, multi-national validation process in the field of postoperative pain. The IPO was applied to a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 13 total of 9,727 patients in Europe and Israel. It achieved satisfactory psychometric quality both for reliability and for validity. . The approach taken in this study, to assess reliability and validity of a questionnaire for a combination of languages, has been rarely used 5 . Nevertheless, we achieved satisfactory statistical results. However, it may only be valid when the languages have a high degree of similarity by belonging to the same language family like it is the case here, since most of the languages involved belong to the Indo-European language family. This similarity of languages was also a given in the study cited above 5 .
The factor analysis conducted on phase 2 data generated a three factor structure unlike in phase 1, where four factors resulted (see also Supplemental Information 2 for phase 1 data). The two separate factors "pain intensity and interference" and "affective impairment" in phase 1 combined to one composite factor in phase 2, where only 2 affective impairment items ("anxious" and "helpless") remained. From the perspective of construct validity this combination makes sense. Interference of pain with emotional aspects could be regarded as one facet of interference with "function", in this case emotional functioning.
Some instruments for pain measurement follow this notion and ask comprehensively for "pain interference with mood" 27, 19, 21, 28 . Some authors have reported low factor loadings of "interference with sleep" for their instruments measuring pain interference 30, 36 . However, even after combining the two original items on sleep interference ("falling asleep" and "staying asleep") into one ("interference with sleep") in the IPO, this item still has a high factor loading of 0.714 in our analysis. The low loading of the item "interference with breathing/coughing" (0.43) can be explained by left-skewed distribution and its floor effect for orthopedic patients (median 0, m=1.11), whereas in general surgery the values are higher (median 1, m=2.64).
Overall reliability of the IPO with a Cronbach"s alpha of 0.86 is satisfactory and in line with comparable validation studies 17, 2, 13, 39, 22, 32 . The high Cronbach"s alpha of 0.89 for the subscale "pain intensity and pain interference (physical and emotional)" confirms the homogeneity of . The low values for these subscales have substance matter explanations: Their items do not follow the classic notion of measurement of one dimension. This is particularly true for the "perceptions of care" scale. Nevertheless, all three components of this scale convey very important information and are needed in the questionnaire.
Especially for the subscale "perceptions of care" it may however be worth considering whether the 3 items concerned should be treated separately instead of combining them into a scale. In the case of "adverse events", a common scale may make more sense but it should be noted that we do not expect these items to be highly correlated as different approaches to pain treatment can lead to different patterns of adverse events.
Substantial differences in pain treatment outcomes in various surgical disciplines are documented 27, 41 . The criterion to establish discriminant validity used in this study was therefore the outcome difference between the two disciplines general and orthopedic surgery. Indeed, the significant outcome differences found in our study between general surgery and orthopedic surgery patients confirm discriminant validity of the instrument. Pain intensity and pain interference is increased in orthopedic patients. The increased mean score for "interference with breathing/coughing" in the general surgery patient group is also plausible given the surgical sites involved. The increased values in the items "percentage of pain relief from all pain treatments combined (medicine and non-medicine)" and "satisfaction with pain treatment" in general surgery patients are well in line with the lower pain intensity and functional interference values in this discipline. The increased score for the item "Participation in decision making" in orthopedic patients cannot be explained easily and may mirror differences in provider practices or patient populations in the two surgical disciplines in question.
In contrast to the APS-POQ-R, our questionnaire asks patients about chronic pain before surgery. This combination may allow gaining new insights into the interaction between 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 
Limitations
A number of limitations apply to this study. First, not all factors potentially influencing patients" pain outcomes could be collected, which may limit the range of additional research questions that can be addressed with the currently collected data. Specifically, we did not collect data about socioeconomic status and level of education, though there is evidence indicating that both are influential in patient"s assessment of pain 9, 18, 7 . PAIN OUT records ethnicity of patients in the demographics section of the questionnaire in countries where this is recorded, yet this task remains a challenge. Interestingly, cultural differences in approaching these issues and deviating attitudes about political correctness throughout Europe, constituting themselves part of ethnical differences, make it difficult to obtain consistent data on patient ethnicity.
The validity of the IPO can only be assumed for the patient population contributing to this study, i.e. adults with normal cognitive functioning. Children, cognitively impaired patients, and other languages are excluded.
It would have been interesting to compare outcomes between the different countries involved in the project. However, apart from one country with three clinical sites for data collection, all other countries contributed with data from only one clinical site. At this stage of the project comparisons between countries have to be treated with caution, since differences found may well be due to site specific effects rather than language or country related differences. So far, we know hardly anything about outcome differences in various countries. At the current stage, outcome differences between countries would be too weak criteria for discriminant validity and would therefore be no useful approach in a validation study. However, in-depth 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 16 analysis of country specific outcome differences are currently carried out and a separate publication addressing this topic is in preparation.
In the setting of postoperative pain it might be worthwhile to focus further research on a better adaptation of pain interference items on the surgical discipline in question. E.g. for maxillofacial surgery it could be useful to have patients assessing "pain interference with eating/chewing". Further research is underway to examine variations in treatment patterns and how these interact with patient outcomes.
Since this was the first time the IPO was used in a larger patient population further studies need to cross-validate and confirm the dimensionality, reliability, and validity of the IPO.
Conclusions
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Internal consistency reliability
Cronbach's alpha and related statistics were calculated at item level (see Table 2 ) for the 18 NRS items and for the subscales identified in factor analysis (see Table 3 ). Overall
Cronbach's alpha was 0.88. At the subscale level internal consistency was best for 'pain intensity and interference' (r=.89), followed by 'affective impairment' (r=.87) and 'adverse effects' (r=.67). The 'perceptions of care' subscale showed the lowest internal consistency (r=.53). Tables   Table 4 summarizes to what extent the 18 NRS items differentiated between patients treated in general surgery versus in orthopaedic wards based on Mann-Whitney-U tests. All pain severity and interference items were significantly increased in patients treated in orthopaedic wards. Items 'percentage of pain relief' and 'satisfaction with pain treatment' were significantly decreased, indicating the same direction of association. Average scores were also higher in all affective items, although these differences for the items 'feeling anxious'
Discriminant validity
and 'feeling frightened' were not significant. The adverse effect 'nausea' was significantly higher in the general surgery patient group. The item 'participation in decision making'
showed significantly higher scores in patients treated in orthopaedic wards, who also received more information of pain treatment and used more frequently non-medicine methods of pain relief. Site of surgery, elsewhere, both (site of surgery and elsewhere)
